Roy H. Perlis, MD, MSc
Disclosure: Roy H. Perlis, MD, MSc, has disclosed that he has received grants for educational activities from, and served as an advisor or consultant to, AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, and Pfizer.

Michael E. Thase, MD
Disclosure: Michael E. Thase, MD, has disclosed that he has served as an advisor or consultant to AstraZeneca, Bristol-Myers Squibb, Cephalon, Cyberonics, Eli Lilly, Forest Laboratories, GlaxoSmithKline, Janssen Pharmaceutica, MedAvante, Neuronetics, Novartis, Organon, Sepracor, Shire US, Supernus, and Wyeth. Dr. Thase has also disclosed that he has served on the speaker's bureau for AstraZeneca, Bristol-Myers Squibb, Cyberonics, Eli Lilly, GlaxoSmithKline, Organon, sanofi-aventis, and Wyeth Pharmaceuticals, and has given expert testimony for Jones Day (Wyeth Litigation), Phillips Lytle (GlaxoSmithKline Litigation), and Pepper Hamilton LLP (Zyprexa Litigation). Dr. Thase has also disclosed that he has equity holdings in MedAvante, and has received royalty or other income from American Psychiatric Publishing, Guilford Publications, Herald House, and W.W. Norton & Company. Dr. Thase has also disclosed that his spouse is employed as the Senior Medical Director at Advogent (Formerly Cardinal Health), and he has received pharmaceutical grants/research from Eli Lilly and Company and Sepracor, Inc.

Terence A. Ketter, MD
Disclosure: Terence A. Ketter, MD, has disclosed that he has received grant/research support from Abbott Laboratories, AstraZeneca Pharmaceuticals, Bristol-Myers Squibb, Cephalon, Eli Lilly, GlaxoSmithKline, Pfizer, Repligen, and Wyeth, and that he has served as a consultant to Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Janssen Pharmaceutica, Jazz Pharmaceuticals, Novartis, Solvay, Valeant, Vanda, and Wyeth. Dr. Ketter has also disclosed that he has received lecture honoraria from Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, and Otsuka Pharmaceuticals. Dr. Ketter has also disclosed that his wife is an employee of Johnson & Johnson.

Christoph Correll, MD
Disclosure: Christoph Correll, MD, has disclosed that he has received grants for educational activities from AstraZeneca, Bristol-Myers Squibb, and Otsuka. Dr. Correll has also disclosed that he has served as an advisor or consultant to AstraZeneca, Bristol-Myers Squibb, Otsuka, Eli Lilly, Janssen, Intra-Cellular Therapies, Organon, Pfizer, Solvay, Wyeth, Vanda, and Supernus. Dr. Correll has also disclosed that he has served on the speaker's bureau of AstraZeneca, Bristol-Myers Squibb, Otsuka, and Janssen.

Robert Chevrier
Disclosure: Robert Chevrier has disclosed no relevant financial relationships.